Evidence 1
Activity
Activity
Antibacterial
Source & Reference
NA
Other
SAAP-148 shows broad activity against the ESKAPE pathogens in 50% plasma, including E. faecium LUH15122 (LC99.9 6.4 uM), S. aureus LUH14616 (3.2-12.8), K. pneumoniae LUH15104 (12.8-25.6 uM), A. baumannii RUH875 (1.6-3.2 uM), P. aeruginosa LUH15103 (12.8-25.6 uM), E. cloacae LUH15114 (3.2-12.8 uM), and E. coli LUH15117 (6.4 uM). Fast killing.